SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 58.08+0.9%3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Biomaven who wrote (14452)12/2/2004 5:29:27 PM
From: Arthur Radley  Read Replies (2) of 52153
 
Could this be for real!!!!!!!!!!!!
++++++++++++++++++++++++++++++++++++++++++++++
Rita Medical moves on cancer trial

By Ciara Linnane, CBS.MarketWatch.com
Last Update: 4:14 PM ET Dec. 2, 2004


NEW YORK (CBS.MW) -- Shares of Rita Medical Systems surged as much as 67 percent Thursday, after it reported positive results for its radio-frequency ablation technology in a trial of lung cancer patients.



The stock ended up 28 percent at $3.99, having earlier touched a high of $5.23. Volume of 11 million shares traded was about 85 times the issue's average full-day volume.

Rita Medical's (RITA: news, chart, profile) RFA system, which uses radio-frequency energy to heat tissue to a high enough temperature to kill cells, achieved a 91 percent survival rate in a trial of patients with primary nonsmall-cell lung cancer after both 12 months and 18 months, the company said in a statement.

Survival among patients with metastases to the lung stood at 88 percent after 12 months and 82 percent at 18 months.

The trial results were reported by Professor Riccardo Lencioni, head of diagnostic and interventional radiology at the University of Pisa, Italy, at the Radiological Society of North America's annual meeting in Chicago.


"We believe that radio-frequency ablation should be considered a viable alternate or complementary treatment for the many patients with pulmonary tumors who unfortunately can not undergo surgical resection," said Lencioni.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext